Company intelligence / Profile preview

Paperplane Therapeutics

Ownership: Private
Development stage: Other

Overview

Paperplane Therapeutics has developed clinically validated virtual reality therapies that have demonstrated efficacy in reducing pain and anxiety for patients—especially children—undergoing various medical and dental procedures. Their technology is being used to minimize the need for general anesthesia, particularly in pediatric neuroradiology, with positive feedback from clinicians at leading institutions[1].

Therapeutic areas: PsychiatryOther
Modalities: Non-pharmacological therapyDevice (Virtual Reality-based therapy)
Industry: Digital Health Medical Devices

Partnerships

CHU Sainte-Justine Hospital (clinical implementation/trials)[1]

Beyond the preview

Go deeper on Paperplane Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paperplane Therapeutics.

Explore the full profile